GR3031539T3 - Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents. - Google Patents
Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents.Info
- Publication number
- GR3031539T3 GR3031539T3 GR990402626T GR990402626T GR3031539T3 GR 3031539 T3 GR3031539 T3 GR 3031539T3 GR 990402626 T GR990402626 T GR 990402626T GR 990402626 T GR990402626 T GR 990402626T GR 3031539 T3 GR3031539 T3 GR 3031539T3
- Authority
- GR
- Greece
- Prior art keywords
- poly
- heteroaroylguanidines
- medicaments
- preparation
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4415873A DE4415873A1 (de) | 1994-05-05 | 1994-05-05 | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3031539T3 true GR3031539T3 (en) | 2000-01-31 |
Family
ID=6517371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990402626T GR3031539T3 (en) | 1994-05-05 | 1999-10-15 | Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6093729A (el) |
| EP (1) | EP0682017B1 (el) |
| JP (1) | JP3774771B2 (el) |
| KR (1) | KR950032129A (el) |
| CN (1) | CN1117045A (el) |
| AT (1) | ATE183179T1 (el) |
| AU (1) | AU693861B2 (el) |
| CA (1) | CA2148666A1 (el) |
| DE (2) | DE4415873A1 (el) |
| DK (1) | DK0682017T3 (el) |
| ES (1) | ES2136767T3 (el) |
| FI (1) | FI952117A (el) |
| GR (1) | GR3031539T3 (el) |
| HU (1) | HUT72089A (el) |
| IL (1) | IL113606A0 (el) |
| NO (1) | NO304830B1 (el) |
| NZ (1) | NZ272058A (el) |
| TW (1) | TW429252B (el) |
| ZA (1) | ZA953588B (el) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| DE19548812A1 (de) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation |
| CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
| DE19621482A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| JP3652708B2 (ja) | 1997-03-06 | 2005-05-25 | トーアエイヨー株式会社 | シクロアルカ［ｂ］ピリジン−３−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品 |
| WO1998055475A1 (en) * | 1997-06-02 | 1998-12-10 | Fujisawa Pharmaceutical Co., Ltd. | Guanidine deriviatives as inhibitors of na+/h+ exchange in cells |
| CA2316944A1 (en) | 1998-02-20 | 1999-08-26 | Mitsuru Shiraishi | Aminoguanidinehydrazone derivative, production and use thereof |
| WO2000075115A1 (fr) | 1999-06-03 | 2000-12-14 | Takeda Chemical Industries, Ltd. | Preparations s'administrant par voie nasale |
| JP5030587B2 (ja) * | 2003-06-26 | 2012-09-19 | バイオトロン・リミテッド | 抗ウイルスアシルグアニジン化合物および方法 |
| CN104370813A (zh) * | 2014-10-22 | 2015-02-25 | 上海大学 | 异喹啉-6-甲醛的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| DE59307360D1 (de) * | 1992-02-15 | 1997-10-23 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0556674B1 (de) * | 1992-02-15 | 1996-06-19 | Hoechst Aktiengesellschaft | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
| ES2152938T3 (es) * | 1992-09-28 | 2001-02-16 | Hoechst Ag | 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos. |
-
1994
- 1994-05-05 DE DE4415873A patent/DE4415873A1/de not_active Withdrawn
- 1994-09-30 TW TW083109021A patent/TW429252B/zh active
-
1995
- 1995-05-02 ES ES95106596T patent/ES2136767T3/es not_active Expired - Lifetime
- 1995-05-02 DE DE59506564T patent/DE59506564D1/de not_active Expired - Lifetime
- 1995-05-02 EP EP95106596A patent/EP0682017B1/de not_active Expired - Lifetime
- 1995-05-02 DK DK95106596T patent/DK0682017T3/da active
- 1995-05-02 AT AT95106596T patent/ATE183179T1/de not_active IP Right Cessation
- 1995-05-02 JP JP10854795A patent/JP3774771B2/ja not_active Expired - Fee Related
- 1995-05-03 AU AU17861/95A patent/AU693861B2/en not_active Ceased
- 1995-05-03 IL IL11360695A patent/IL113606A0/xx unknown
- 1995-05-03 CN CN95105390A patent/CN1117045A/zh active Pending
- 1995-05-03 FI FI952117A patent/FI952117A/fi unknown
- 1995-05-03 NZ NZ272058A patent/NZ272058A/en unknown
- 1995-05-04 HU HU9501285A patent/HUT72089A/hu unknown
- 1995-05-04 CA CA002148666A patent/CA2148666A1/en not_active Abandoned
- 1995-05-04 NO NO951736A patent/NO304830B1/no not_active IP Right Cessation
- 1995-05-04 KR KR1019950011160A patent/KR950032129A/ko not_active Application Discontinuation
- 1995-05-04 ZA ZA953588A patent/ZA953588B/xx unknown
-
1998
- 1998-11-18 US US09/195,098 patent/US6093729A/en not_active Expired - Lifetime
-
1999
- 1999-10-15 GR GR990402626T patent/GR3031539T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT72089A (en) | 1996-03-28 |
| CA2148666A1 (en) | 1995-11-06 |
| CN1117045A (zh) | 1996-02-21 |
| JP3774771B2 (ja) | 2006-05-17 |
| NO304830B1 (no) | 1999-02-22 |
| FI952117A (fi) | 1995-11-06 |
| ZA953588B (en) | 1996-06-16 |
| DE4415873A1 (de) | 1995-11-09 |
| AU693861B2 (en) | 1998-07-09 |
| NO951736D0 (no) | 1995-05-04 |
| AU1786195A (en) | 1995-11-16 |
| US6093729A (en) | 2000-07-25 |
| NO951736L (no) | 1995-11-06 |
| DK0682017T3 (da) | 1999-12-13 |
| NZ272058A (en) | 1996-02-27 |
| FI952117A0 (fi) | 1995-05-03 |
| EP0682017A1 (de) | 1995-11-15 |
| ATE183179T1 (de) | 1999-08-15 |
| EP0682017B1 (de) | 1999-08-11 |
| KR950032129A (ko) | 1995-12-20 |
| IL113606A0 (en) | 1995-08-31 |
| ES2136767T3 (es) | 1999-12-01 |
| JPH0841028A (ja) | 1996-02-13 |
| DE59506564D1 (de) | 1999-09-16 |
| TW429252B (en) | 2001-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3031539T3 (en) | Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents. | |
| FI943569A0 (fi) | Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia | |
| MX9100062A (es) | Composiciones en polvo para revestimiento para la fabricacion de las mismas | |
| KR930701456A (ko) | 세팔로스포린 및 동족체, 제조 및 제약학적 조성물 | |
| ES2146297T3 (es) | Nuevos derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| DE69129482D1 (de) | Zusammengesetztes Femurschaftimplantat mit erhöhter Halsfestigkeit | |
| MX9301298A (es) | Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| DK431489A (da) | Lipoprotein i (ompi) af pseudomonas aeruginosa, dets fremstilling og anvendelse | |
| NZ238795A (en) | N-((bis(phenyl)methylthio)alkyl)benzene alkylamine derivatives; their preparation and pharmaceutical compositions | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| EP0279633A3 (en) | Anticonvulsant agents | |
| ITRM920039A1 (it) | Uso dell'acido ialuronico lubrificante di protesi oculari. | |
| BR9401933A (pt) | Processop ara a preparação de uma succinimida substituída com poliolefina opcionalmente halogenada, a referida succinimida substituída com poliolefina opcionalmente halogenada, composição de óleo lubrificante e concentrado de aditivo | |
| DK160807C (da) | Immunomodulerende laegemiddel af biologisk oprindelse samt fremgangsmaade til fremstilling deraf | |
| FR2690073B1 (fr) | Prothèse de réparation de la coiffe de muscles rotateurs de l'épaule. | |
| DK114397A (da) | Båndtransportør med "drypnæse" | |
| GB9003485D0 (en) | True universal scribe & counter scribe joint | |
| ES293201Y (es) | Pieza de articulacion para monturas de gafas | |
| FR2644858B1 (fr) | Joint d'etancheite pour roulement | |
| ITMI911344A1 (it) | Associazione farmaceutica ad attivita' antineoplastica | |
| BR9001854A (pt) | Aparelho para a fixacao,sobre a extremidade de uma esteira transportadora,de uma carreira de grampos de juncao | |
| KR950019591U (ko) | 트리포드식 등속 죠인트 | |
| ITMI911335A1 (it) | Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| ITMI911298A1 (it) | Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| ES1024974Y (es) | Contenedor para la conservacion fisiologica temporal de piezas dentarias. |